These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 8672510

  • 21. Synthetic peptides and fluorogenic substrates related to the reactive site sequence of Kunitz-type inhibitors isolated from Bauhinia: interaction with human plasma kallikrein.
    Oliva ML, Santomauro-Vaz EM, Andrade SA, Juliano MA, Pott VJ, Sampaio MU, Sampaio CA.
    Biol Chem; 2001 Jan; 382(1):109-13. PubMed ID: 11258660
    [Abstract] [Full Text] [Related]

  • 22. Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures.
    Slon-Usakiewicz JJ, Sivaraman J, Li Y, Cygler M, Konishi Y.
    Biochemistry; 2000 Mar 07; 39(9):2384-91. PubMed ID: 10694407
    [Abstract] [Full Text] [Related]

  • 23. Structure-based design of inhibitors of NS3 serine protease of hepatitis C virus.
    Frecer V, Kabelác M, De Nardi P, Pricl S, Miertus S.
    J Mol Graph Model; 2004 Jan 07; 22(3):209-20. PubMed ID: 14629979
    [Abstract] [Full Text] [Related]

  • 24. Comparative binding energy analysis considering multiple receptors: a step toward 3D-QSAR models for multiple targets.
    Murcia M, Morreale A, Ortiz AR.
    J Med Chem; 2006 Oct 19; 49(21):6241-53. PubMed ID: 17034130
    [Abstract] [Full Text] [Related]

  • 25. Three recombinant serine proteinase inhibitors expressed from the coding region of the thrombin inhibitor dipetalogastin.
    Mende K, Lange U, Nowak G.
    Insect Biochem Mol Biol; 2004 Sep 19; 34(9):971-9. PubMed ID: 15350616
    [Abstract] [Full Text] [Related]

  • 26. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
    Qasim MA, Lu SM, Ding J, Bateman KS, James MN, Anderson S, Song J, Markley JL, Ganz PJ, Saunders CW, Laskowski M.
    Biochemistry; 1999 Jun 01; 38(22):7142-50. PubMed ID: 10353824
    [Abstract] [Full Text] [Related]

  • 27. The ornithodorin-thrombin crystal structure, a key to the TAP enigma?
    van de Locht A, Stubbs MT, Bode W, Friedrich T, Bollschweiler C, Höffken W, Huber R.
    EMBO J; 1996 Nov 15; 15(22):6011-7. PubMed ID: 8947023
    [Abstract] [Full Text] [Related]

  • 28. Purification and characterization of the major cationic kallikrein inhibitor in bovine pituitary gland.
    Ikekita M, Jone CS, Kamo M, Tsugita A, Kizuki K, Moriya H.
    Protein Seq Data Anal; 1992 Nov 15; 5(1):7-11. PubMed ID: 1283464
    [Abstract] [Full Text] [Related]

  • 29. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
    Rupin A, Mennecier P, Lila C, de Nanteuil G, Verbeuren TJ.
    Thromb Haemost; 1997 Oct 15; 78(4):1221-7. PubMed ID: 9364988
    [Abstract] [Full Text] [Related]

  • 30. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin.
    Liu Y, Stack SM, Lakka SS, Khan AJ, Woodley DT, Rao JS, Rao CN.
    Arch Biochem Biophys; 1999 Oct 01; 370(1):112-8. PubMed ID: 10496984
    [Abstract] [Full Text] [Related]

  • 31. Substrate-guided design of a potent and selective kallikrein-related peptidase inhibitor for kallikrein 4.
    Swedberg JE, Nigon LV, Reid JC, de Veer SJ, Walpole CM, Stephens CR, Walsh TP, Takayama TK, Hooper JD, Clements JA, Buckle AM, Harris JM.
    Chem Biol; 2009 Jun 26; 16(6):633-43. PubMed ID: 19549601
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Structure-function relationship of serine protease-protein inhibitor interaction.
    Otlewski J, Jaskólski M, Buczek O, Cierpicki T, Czapińska H, Krowarsch D, Smalas AO, Stachowiak D, Szpineta A, Dadlez M.
    Acta Biochim Pol; 2001 Jun 26; 48(2):419-28. PubMed ID: 11732612
    [Abstract] [Full Text] [Related]

  • 34. Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant.
    Zhang E, St Charles R, Tulinsky A.
    J Mol Biol; 1999 Feb 05; 285(5):2089-104. PubMed ID: 9925787
    [Abstract] [Full Text] [Related]

  • 35. Use of phage display for the generation of human antibodies that neutralize factor IXa function.
    Suggett S, Kirchhofer D, Hass P, Lipari T, Moran P, Nagel M, Judice K, Schroeder K, Tom J, Lowman H, Adams C, Eaton D, Devaux B.
    Blood Coagul Fibrinolysis; 2000 Jan 05; 11(1):27-42. PubMed ID: 10691097
    [Abstract] [Full Text] [Related]

  • 36. Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping.
    Landro JA, Raybuck SA, Luong YP, O'Malley ET, Harbeson SL, Morgenstern KA, Rao G, Livingston DJ.
    Biochemistry; 1997 Aug 05; 36(31):9340-8. PubMed ID: 9235976
    [Abstract] [Full Text] [Related]

  • 37. Highly selective mechanism-based thrombin inhibitors: structures of thrombin and trypsin inhibited with rigid peptidyl aldehydes.
    Krishnan R, Zhang E, Hakansson K, Arni RK, Tulinsky A, Lim-Wilby MS, Levy OE, Semple JE, Brunck TK.
    Biochemistry; 1998 Sep 01; 37(35):12094-103. PubMed ID: 9724521
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Distal hinge of plasminogen activator inhibitor-1 involves its latency transition and specificities toward serine proteases.
    Wang Q, Shaltiel S.
    BMC Biochem; 2003 Jul 08; 4():5. PubMed ID: 12848892
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.